---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-237150"
form_type: "8-K"
ticker: "TPST"
cik: "0001544227"
company_name: "Tempest Therapeutics, Inc."
filed_at: "2026-05-22T21:05:53+00:00"
generated_at: "2026-05-22T21:09:46.337732+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Three directors resign from Tempest Therapeutics board effective May 22, 2026

## Summary
- Stephen Brady, Michael Raab, and Christine Pellizzari resigned from the Tempest board on May 22, 2026.
- Resignations not due to any disagreement with the company on operations, policies, or practices.
- Separation agreements waive accrued unpaid director retainer fees; stock options and indemnification remain.
- Board size reduced by three members; no replacements announced.

## SEC filing metadata
- accession: 0001193125-26-237150
- form_type: 8-K
- ticker: TPST
- cik: 0001544227
- company_name: Tempest Therapeutics, Inc.
- filed_at: 2026-05-22T21:05:53+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1544227/000119312526237150/0001193125-26-237150-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1544227/000119312526237150/d29824d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-237150
- JSON: https://secwatch.observer/filing/0001193125-26-237150.json
- Plain text: https://secwatch.observer/filing/0001193125-26-237150.txt

## Source-grounded claims
- claim_id: 5310339e24
  claim: Christine Pellizzari resigned as Director at Tempest Therapeutics, Inc..
  evidence_excerpt: On May 22, 2026, each of Mr. Stephen Brady, Mr. Michael Raab and Ms. Christine Pellizzari notified Tempest Therapeutics, Inc. (the “Company”) of his or her resignation from the Board of Directors of the Company (the “Board”), effective as of such date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1544227/000119312526237150/0001193125-26-237150-index.htm
- claim_id: 6b76a16d94
  claim: Michael Raab resigned as Director at Tempest Therapeutics, Inc..
  evidence_excerpt: On May 22, 2026, each of Mr. Stephen Brady, Mr. Michael Raab and Ms. Christine Pellizzari notified Tempest Therapeutics, Inc. (the “Company”) of his or her resignation from the Board of Directors of the Company (the “Board”), effective as of such date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1544227/000119312526237150/0001193125-26-237150-index.htm
- claim_id: 7d5fc56857
  claim: Stephen Brady resigned as Director at Tempest Therapeutics, Inc..
  evidence_excerpt: On May 22, 2026, each of Mr. Stephen Brady, Mr. Michael Raab and Ms. Christine Pellizzari notified Tempest Therapeutics, Inc. (the “Company”) of his or her resignation from the Board of Directors of the Company (the “Board”), effective as of such date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1544227/000119312526237150/0001193125-26-237150-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.